HIGHFDA DRUG
Alvogen Recalls Levothyroxine Sodium Tablets Due to Mix-Up
Alvogen, Inc. recalled Levothyroxine Sodium Tablets on January 21, 2026, after a pharmacy reported a mix-up with dosages. Some bottles contained 88 mcg tablets instead of the prescribed 150 mcg. The recall affects 1,000 tablets from lot # MHA21825, with an expiration date of December 31, 2027.
LEVOTHYROXINE SODIUM
Product Mix-Up: